Fibrinolytic Activity and Platelet Function in Subjects with Obstructive Sleep Apnoea and a Patent Foramen Ovale: Is There an Option for Prevention of Ischaemic Stroke?

Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur through a patent foramen ovale (PFO) during periods of apnoea, we investigated nocturnal changes in fibrinolytic activity and platelet function...

Full description

Saved in:
Bibliographic Details
Published inStroke Research and Treatment Vol. 2012; no. 2012; pp. 584 - 590
Main Authors Reggiani, Monica, Karttunen, Vesa, Wartiovaara-Kautto, Ulla, Riutta, Asko, Uchiyama, Shinichiro, Hillbom, Matti
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Limiteds 01.01.2012
Hindawi Puplishing Corporation
Hindawi Publishing Corporation
Wiley
Online AccessGet full text
ISSN2090-8105
2042-0056
2042-0056
DOI10.1155/2012/945849

Cover

Abstract Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur through a patent foramen ovale (PFO) during periods of apnoea, we investigated nocturnal changes in fibrinolytic activity and platelet function in subjects who had OSA with or without PFO and in controls. We determined plasminogen activator inhibitor 1 (PAI-1) activity and antigen and platelet activation parameters. The severity of OSA was verified by polygraphy and PFO was detected by ear oximetry. We found a higher PAI-1 activity and antigen and a lower ratio of 2,3-dinor-PGF1α to 2,3-dinor-TXB2 in the subjects with OSA than in the controls. Linear regression analysis showed the apnoea-hypopnoea index (β-coefficient, 0.499; P=0.032) and PFO (β-coefficient, 0.594; P=0.015) to be associated independently with PAI-1 activity in the morning, while the increment in PAI-1:Ag from evening to morning was significantly associated with the presence of PFO (rs=0.563, P=0.002). Both OSA and PFO reduce fibrinolytic activity during nocturnal sleep. We hypothesize that subjects having both OSA and PFO may develop a more severe prothrombotic state during sleep than those having either OSA or PFO alone.
AbstractList Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur through a patent foramen ovale (PFO) during periods of apnoea, we investigated nocturnal changes in fibrinolytic activity and platelet function in subjects who had OSA with or without PFO and in controls. We determined plasminogen activator inhibitor 1 (PAI-1) activity and antigen and platelet activation parameters. The severity of OSA was verified by polygraphy and PFO was detected by ear oximetry. We found a higher PAI-1 activity and antigen and a lower ratio of 2,3-dinor-PGF1α to 2,3-dinor-TXB2 in the subjects with OSA than in the controls. Linear regression analysis showed the apnoea-hypopnoea index (β-coefficient, 0.499; P=0.032) and PFO (β-coefficient, 0.594; P=0.015) to be associated independently with PAI-1 activity in the morning, while the increment in PAI-1:Ag from evening to morning was significantly associated with the presence of PFO (rs=0.563, P=0.002). Both OSA and PFO reduce fibrinolytic activity during nocturnal sleep. We hypothesize that subjects having both OSA and PFO may develop a more severe prothrombotic state during sleep than those having either OSA or PFO alone.
Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur through a patent foramen ovale (PFO) during periods of apnoea, we investigated nocturnal changes in fibrinolytic activity and platelet function in subjects who had OSA with or without PFO and in controls. We determined plasminogen activator inhibitor 1 (PAI-1) activity and antigen and platelet activation parameters. The severity of OSA was verified by polygraphy and PFO was detected by ear oximetry. We found a higher PAI-1 activity and antigen and a lower ratio of 2,3-dinor-PGF(1α) to 2,3-dinor-TXB(2) in the subjects with OSA than in the controls. Linear regression analysis showed the apnoea-hypopnoea index (β-coefficient, 0.499; P = 0.032) and PFO (β-coefficient, 0.594; P = 0.015) to be associated independently with PAI-1 activity in the morning, while the increment in PAI-1:Ag from evening to morning was significantly associated with the presence of PFO (r(s) = 0.563, P = 0.002). Both OSA and PFO reduce fibrinolytic activity during nocturnal sleep. We hypothesize that subjects having both OSA and PFO may develop a more severe prothrombotic state during sleep than those having either OSA or PFO alone.Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur through a patent foramen ovale (PFO) during periods of apnoea, we investigated nocturnal changes in fibrinolytic activity and platelet function in subjects who had OSA with or without PFO and in controls. We determined plasminogen activator inhibitor 1 (PAI-1) activity and antigen and platelet activation parameters. The severity of OSA was verified by polygraphy and PFO was detected by ear oximetry. We found a higher PAI-1 activity and antigen and a lower ratio of 2,3-dinor-PGF(1α) to 2,3-dinor-TXB(2) in the subjects with OSA than in the controls. Linear regression analysis showed the apnoea-hypopnoea index (β-coefficient, 0.499; P = 0.032) and PFO (β-coefficient, 0.594; P = 0.015) to be associated independently with PAI-1 activity in the morning, while the increment in PAI-1:Ag from evening to morning was significantly associated with the presence of PFO (r(s) = 0.563, P = 0.002). Both OSA and PFO reduce fibrinolytic activity during nocturnal sleep. We hypothesize that subjects having both OSA and PFO may develop a more severe prothrombotic state during sleep than those having either OSA or PFO alone.
Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur through a patent foramen ovale (PFO) during periods of apnoea, we investigated nocturnal changes in fibrinolytic activity and platelet function in subjects who had OSA with or without PFO and in controls. We determined plasminogen activator inhibitor 1 (PAI-1) activity and antigen and platelet activation parameters. The severity of OSA was verified by polygraphy and PFO was detected by ear oximetry. We found a higher PAI-1 activity and antigen and a lower ratio of 2,3-dinor- PGF 1 α to 2,3-dinor-TXB 2 in the subjects with OSA than in the controls. Linear regression analysis showed the apnoea-hypopnoea index ( β -coefficient, 0.499; P = 0.032 ) and PFO ( β -coefficient, 0.594; P = 0.015 ) to be associated independently with PAI-1 activity in the morning, while the increment in PAI-1:Ag from evening to morning was significantly associated with the presence of PFO ( r s = 0.563 , P = 0.002 ). Both OSA and PFO reduce fibrinolytic activity during nocturnal sleep. We hypothesize that subjects having both OSA and PFO may develop a more severe prothrombotic state during sleep than those having either OSA or PFO alone.
Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur through a patent foramen ovale (PFO) during periods of apnoea, we investigated nocturnal changes in fibrinolytic activity and platelet function in subjects who had OSA with or without PFO and in controls. We determined plasminogen activator inhibitor 1 (PAI-1) activity and antigen and platelet activation parameters. The severity of OSA was verified by polygraphy and PFO was detected by ear oximetry. We found a higher PAI-1 activity and antigen and a lower ratio of 2,3-dinor-PGF(1α) to 2,3-dinor-TXB(2) in the subjects with OSA than in the controls. Linear regression analysis showed the apnoea-hypopnoea index (β-coefficient, 0.499; P = 0.032) and PFO (β-coefficient, 0.594; P = 0.015) to be associated independently with PAI-1 activity in the morning, while the increment in PAI-1:Ag from evening to morning was significantly associated with the presence of PFO (r(s) = 0.563, P = 0.002). Both OSA and PFO reduce fibrinolytic activity during nocturnal sleep. We hypothesize that subjects having both OSA and PFO may develop a more severe prothrombotic state during sleep than those having either OSA or PFO alone.
Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur through a patent foramen ovale (PFO) during periods of apnoea, we investigated nocturnal changes in fibrinolytic activity and platelet function in subjects who had OSA with or without PFO and in controls. We determined plasminogen activator inhibitor 1 (PAI-1) activity and antigen and platelet activation parameters. The severity of OSA was verified by polygraphy and PFO was detected by ear oximetry. We found a higher PAI-1 activity and antigen and a lower ratio of 2,3-dinor-PGF 1 α to 2,3-dinor-TXB 2 in the subjects with OSA than in the controls. Linear regression analysis showed the apnoea-hypopnoea index ( β -coefficient, 0.499; P = 0.032) and PFO ( β -coefficient, 0.594; P = 0.015) to be associated independently with PAI-1 activity in the morning, while the increment in PAI-1:Ag from evening to morning was significantly associated with the presence of PFO ( r s = 0.563, P = 0.002). Both OSA and PFO reduce fibrinolytic activity during nocturnal sleep. We hypothesize that subjects having both OSA and PFO may develop a more severe prothrombotic state during sleep than those having either OSA or PFO alone.
Author Wartiovaara-Kautto, Ulla
Karttunen, Vesa
Riutta, Asko
Reggiani, Monica
Uchiyama, Shinichiro
Hillbom, Matti
AuthorAffiliation 5 Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan
3 Department of Clinical Chemistry, Laboratory of Hematology, University of Helsinki and Helsinki University Hospital, Finland
4 Department of Pharmacological Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland
1 Department of Neurology, University of Oulu and Oulu University Hospital, P.O. Box 25, 900029 OYS, Finland
2 Department of Neurology, “A. Avogadro” University, Novara, Italy
AuthorAffiliation_xml – name: 1 Department of Neurology, University of Oulu and Oulu University Hospital, P.O. Box 25, 900029 OYS, Finland
– name: 2 Department of Neurology, “A. Avogadro” University, Novara, Italy
– name: 3 Department of Clinical Chemistry, Laboratory of Hematology, University of Helsinki and Helsinki University Hospital, Finland
– name: 4 Department of Pharmacological Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland
– name: 5 Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan
Author_xml – sequence: 1
  fullname: Reggiani, Monica
– sequence: 2
  fullname: Karttunen, Vesa
– sequence: 3
  fullname: Wartiovaara-Kautto, Ulla
– sequence: 4
  fullname: Riutta, Asko
– sequence: 5
  fullname: Uchiyama, Shinichiro
– sequence: 6
  fullname: Hillbom, Matti
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23259151$$D View this record in MEDLINE/PubMed
BookMark eNqFkk1v1DAQhiNUREvpiTPIRwRa6u8kHECrioVKlXallrPlZCddL1l7cZyt-o_4mUw2baEIiVwcz7zvM7ZnnmcHPnjIspeMvmdMqVNOGT8tpSpk-SQ74lTyCaVKHwz_JZ0UjKrD7KTr1hQ_wUtB5bPskAuuSqbYUfZz5qrofGhvk6vJtE5u59ItsX5JFq1N0EIis95jPHjiPLnsqzXUqSM3Lq3IvOpS7AcTkMsWYEumWx_A7v2WLBDg0R-i3YAn851t4QM578jVCiKgiMy3e3ATIllE2KF62IYGRfXKwgbPdJli-A6fXmRPG9t2cHK3HmffZp-vzr5OLuZfzs-mFxOrcpEmmjGR27xRDBortCp5I6C2nCsNBZM5A8xqnbNCMq2XAipdQd3IqpSVqtBynJ2P3GWwa7ONbmPjrQnWmX0gxGtjI75VCwaaoqSyQDblkkldUA22QJ61TS7EElkfR9a2rzawrPF60baPoI8z3q3MddgZoRgtdI6AN3eAGH700CWzcV0NbWs9hL4zjOdCyryUHKWv_6z1UOS-1Shgo6COoesiNKZ2yQ7vjaVdaxg1w0SZYaLMOFHoefeX5x77b_XbUb1yfmlv3H_Er0YxoAR79SDGqwsuMH8x5q2LLjmzDn302HizQIqiuWCUsj0RmbjkVGOYjlV-b7CWUSUVvwAyPvdu
CitedBy_id crossref_primary_10_3389_fneur_2024_1357348
Cites_doi 10.1182/blood-2004-04-1439
10.7326/0003-4819-142-3-200502010-00010
10.1378/chest.108.3.625
10.1016/S1474-4422(04)00766-5
10.1034/j.1399-3003.2000.16d14.x
10.1111/j.1365-2869.2005.00469.x
10.1378/chest.124.5.1956
10.1111/j.1538-7836.2004.00827.x
10.1212/WNL.51.1.188
10.1161/01.STR.32.6.1271
10.1161/01.CIR.98.21.2241
10.1161/01.STR.25.8.1547
10.1161/01.ATV.20.4.1155
10.1111/j.1538-7836.2005.01420.x
10.1161/01.CIR.0000136587.68725.8E
10.1161/01.STR.32.2.448
10.1093/alcalc/35.6.594
10.1093/sleep/18.3.188
10.1164/ajrccm.162.6.2001048
10.1182/blood-2006-04-011551
10.1161/01.CIR.0000072346.56728.E4
10.1016/0049-3848(89)90233-8
10.1097/00004872-200311000-00002
10.2169/internalmedicine.37.127
10.1016/j.ccl.2004.10.002
10.1378/chest.113.1.91
10.1161/01.STR.31.2.398
10.1053/smrv.2002.0261
10.1007/s11325-006-0060-3
10.1111/j.1440-1681.1991.tb01490.x
10.1056/NEJMoa043104
10.5664/jcsm.2026
10.4065/81.5.602
10.1159/000063625
10.1378/chest.125.5.1768
ContentType Journal Article
Contributor Wartiovaara-Kautto, Ulla
Karttunen, Vesa
Riutta, Asko
Reggiani, Monica
Uchiyama, Shinichiro
Hillbom, Matti
Contributor_xml – sequence: 1
  fullname: Reggiani, Monica
– sequence: 2
  fullname: Karttunen, Vesa
– sequence: 3
  fullname: Wartiovaara-Kautto, Ulla
– sequence: 4
  fullname: Riutta, Asko
– sequence: 5
  fullname: Uchiyama, Shinichiro
– sequence: 6
  fullname: Hillbom, Matti
Copyright Copyright © 2012 Monica Reggiani et al.
Copyright © 2012 Monica Reggiani et al. 2012
Copyright_xml – notice: Copyright © 2012 Monica Reggiani et al.
– notice: Copyright © 2012 Monica Reggiani et al. 2012
DBID 188
ADJCN
AHFXO
RHU
RHW
RHX
AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1155/2012/945849
DatabaseName Chinese Electronic Periodical Services (CEPS)
الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic
CrossRef
PubMed

Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2042-0056
Editor Castilla-Guerra, Luis
Editor_xml – sequence: 1
  givenname: Luis
  surname: Castilla-Guerra
  fullname: Castilla-Guerra, Luis
EndPage 590
ExternalDocumentID oai_doaj_org_article_ef89048225024146806ea86beaaf733d
PMC3510867
23259151
10_1155_2012_945849
510323
P20150731001_201212_201706150055_201706150055_584_590
Genre Journal Article
GroupedDBID ---
188
24P
2UF
4.4
5VS
6PF
AAFWJ
AAJEY
AAWTL
ABDBF
ACGFO
ADBBV
ADRAZ
AFPKN
AHMBA
AINHJ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CEFSP
CNMHZ
DIK
E3Z
EBD
EBS
EJD
ESX
F5P
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M48
M~E
O5R
O5S
OK1
PGMZT
RHX
RNS
RPM
TR2
TUS
TUXDW
UZ5
3V.
7RV
7X7
8AO
8FI
8FJ
8G5
ABUWG
ADJCN
AFKRA
AHFXO
AZQEC
BENPR
BKEYQ
BPHCQ
BVXVI
CCPQU
DWQXO
FYUFA
GNUQQ
GUQSH
H13
HMCUK
M2O
NAPCQ
PADUT
PIMPY
PQQKQ
PROAC
UKHRP
RHU
RHW
0R~
AAYXX
ACCMX
ACUHS
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
NPM
PPXIY
7X8
5PM
ID FETCH-LOGICAL-a573t-61137a7f51efa36592f3eca2256e81471e7a7667184166d3eb6becf4b94b5bfa3
IEDL.DBID RHX
ISSN 2090-8105
2042-0056
IngestDate Wed Aug 27 01:13:09 EDT 2025
Thu Aug 21 18:10:30 EDT 2025
Fri Sep 05 08:21:18 EDT 2025
Mon Jul 21 06:03:35 EDT 2025
Tue Jul 01 01:16:21 EDT 2025
Thu Apr 24 22:58:35 EDT 2025
Sun Jun 02 18:49:35 EDT 2024
Tue Nov 26 16:45:47 EST 2024
Tue Oct 01 22:51:43 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2012
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
http://creativecommons.org/licenses/by/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a573t-61137a7f51efa36592f3eca2256e81471e7a7667184166d3eb6becf4b94b5bfa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Academic Editor: Luis Castilla-Guerra
OpenAccessLink https://dx.doi.org/10.1155/2012/945849
PMID 23259151
PQID 1273447942
PQPubID 23479
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_ef89048225024146806ea86beaaf733d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3510867
proquest_miscellaneous_1273447942
pubmed_primary_23259151
crossref_citationtrail_10_1155_2012_945849
crossref_primary_10_1155_2012_945849
hindawi_primary_10_1155_2012_945849
emarefa_primary_510323
airiti_journals_P20150731001_201212_201706150055_201706150055_584_590
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-01-01
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: United States
PublicationTitle Stroke Research and Treatment
PublicationTitleAlternate Stroke Res Treat
PublicationYear 2012
Publisher Hindawi Limiteds
Hindawi Puplishing Corporation
Hindawi Publishing Corporation
Wiley
Publisher_xml – name: Hindawi Limiteds
– name: Hindawi Puplishing Corporation
– name: Hindawi Publishing Corporation
– name: Wiley
References (21) 2006; 10
(28) 1995; 108
(27) 1998; 37
(2) 2004; 3
(26) 1991; 18
(13) 2005; 3
(19) 2000; 35
(36) 2003; 7
(15) 2006; 108
(3) 2005; 353
(25) 1998; 98
(31) 2004; 125
(1) 2005; 142
(7) 2003; 124
(37) 2012; 8
(9) 2001; 32
(8) 2006; 81
(29) 1998; 51
(33) 2005; 14
(18) 1994; 25
(30) 2002; 69
(11) 2000; 31
(32) 2000; 16
(34) 2002; 25
(4) 2001; 32
(17) 1989; 54
(12) 2004; 104
(10) 2005; 23
(6) 2004; 110
(20) 1995; 18
(5) 2003; 108
(16) 2003; 21
(14) 2000; 20
(22) 2005; 3
(24) 2000; 162
(35) 1998; 113
(23) 2000; 76
22
(31) 1998; 51
24
(28) 1991; 18
(21) 1995; 18
(25) 2000; 76
(20) 2000; 35
(18) 1989; 54
(29) 1998; 37
(26) 2000; 162
(37) 1998; 113
10
(27) 1998; 98
32
33
12
34
13
35
15
16
38
(30) 1995; 108
2
3
5
6
7
8
(36) 2002; 25
(19) 1994; 25
(39) 2012; 8
16282178 - N Engl J Med. 2005 Nov 10;353(19):2034-41
15676269 - Cardiol Clin. 2005 Feb;23(1):65-71
11157181 - Stroke. 2001 Feb;32(2):448-53
16772609 - Blood. 2006 Sep 15;108(6):1903-10
15634264 - J Thromb Haemost. 2005 Jan;3(1):35-45
9674801 - Neurology. 1998 Jul;51(1):188-95
9550591 - Intern Med. 1998 Feb;37(2):127-33
11450024 - Acta Neurochir Suppl. 2000;76:277-8
2501904 - Thromb Res. 1989 May 1;54(3):253-60
11093967 - Alcohol Alcohol. 2000 Nov-Dec;35(6):594-600
12097766 - Respiration. 2002;69(3):229-34
16565866 - Sleep Breath. 2006 Sep;10(3):139-46
15157848 - Lancet Neurol. 2004 Jun;3(6):333-42
15684207 - Ann Intern Med. 2005 Feb 1;142(3):187-97
9826309 - Circulation. 1998 Nov 24;98(21):2241-7
12847053 - Circulation. 2003 Jul 8;108(1):9-12
15136389 - Chest. 2004 May;125(5):1768-75
14597836 - J Hypertens. 2003 Nov;21(11):1983-92
16706256 - Mayo Clin Proc. 2006 May;81(5):602-8
7610315 - Sleep. 1995 Apr;18(3):188-94
16102055 - J Thromb Haemost. 2005 Aug;3(8):1879-83
22893767 - J Clin Sleep Med. 2012;8(4):375-80
14605073 - Chest. 2003 Nov;124(5):1956-67
1914253 - Clin Exp Pharmacol Physiol. 1991 Aug;18(8):551-5
7656607 - Chest. 1995 Sep;108(3):625-30
10764687 - Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1155-61
15315974 - Blood. 2004 Dec 15;104(13):3943-8
11112110 - Am J Respir Crit Care Med. 2000 Dec;162(6):2039-42
10657412 - Stroke. 2000 Feb;31(2):398-403
9440574 - Chest. 1998 Jan;113(1):91-6
8042205 - Stroke. 1994 Aug;25(8):1547-51
16120109 - J Sleep Res. 2005 Sep;14(3):325-7
12489891 - Sleep. 2002 Dec15;25(8):856-62
15249509 - Circulation. 2004 Jul 27;110(4):364-7
12586529 - Sleep Med Rev. 2003 Feb;7(1):35-51
11387486 - Stroke. 2001 Jun;32(6):1271-8
11106207 - Eur Respir J. 2000 Oct;16(4):648-52
References_xml – volume: 81
  start-page: 602
  issue: 5
  year: 2006
  end-page: 608
  ident: 8
  article-title: Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events
– volume: 32
  start-page: 1271
  issue: 6
  year: 2001
  end-page: 1276
  ident: 4
  article-title: Sleep-related breathing disorders and risk of Stroke
– volume: 51
  start-page: 188
  issue: 1
  year: 1998
  end-page: 195
  ident: 29
  article-title: Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome
– volume: 142
  start-page: 187
  issue: 3
  year: 2005
  end-page: 197
  ident: 1
  article-title: Obstructive sleep apnea
– volume: 3
  start-page: 333
  issue: 6
  year: 2004
  end-page: 342
  ident: 2
  article-title: Obstructive sleep apnoea and stroke
– volume: 20
  start-page: 1155
  issue: 4
  year: 2000
  end-page: 1161
  ident: 14
  article-title: Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells
– volume: 108
  start-page: 1903
  issue: 6
  year: 2006
  end-page: 1910
  ident: 15
  article-title: Activation-independent platelet adhesion and aggregation under elevated shear stress
– volume: 14
  start-page: 325
  issue: 3
  year: 2005
  end-page: 327
  ident: 33
  article-title: Platelet function (measured by Platelet Function Analyser—100) and obstructive sleep apnoea
– volume: 21
  start-page: 1983
  issue: 11
  year: 2003
  end-page: 1992
  ident: 16
  article-title: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
– volume: 98
  start-page: 2241
  issue: 21
  year: 1998
  end-page: 2247
  ident: 25
  article-title: High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor
– volume: 8
  start-page: 375
  year: 2012
  end-page: 380
  ident: 37
  article-title: PFO and right-to-left shunting in patients with obstructive sleep apnoea
– volume: 162
  start-page: 2039
  issue: 6
  year: 2000
  end-page: 2042
  ident: 24
  article-title: Fibrinogen levels and obstructive sleep apnea in ischemic stroke
– volume: 113
  start-page: 91
  issue: 1
  year: 1998
  end-page: 96
  ident: 35
  article-title: Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea
– volume: 18
  start-page: 188
  issue: 3
  year: 1995
  end-page: 194
  ident: 20
  article-title: Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients
– volume: 124
  start-page: 1956
  issue: 5
  year: 2003
  end-page: 1967
  ident: 7
  article-title: Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease
– volume: 108
  start-page: 9
  issue: 1
  year: 2003
  end-page: 12
  ident: 5
  article-title: Sleep-disordered breathing and cardiovascular disease
– volume: 125
  start-page: 1768
  issue: 5
  year: 2004
  end-page: 1775
  ident: 31
  article-title: The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome
– volume: 31
  start-page: 398
  issue: 2
  year: 2000
  end-page: 403
  ident: 11
  article-title: Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause
– volume: 16
  start-page: 648
  issue: 4
  year: 2000
  end-page: 652
  ident: 32
  article-title: Platelet function in patients with obstructive sleep apnoea syndrome
– volume: 69
  start-page: 229
  issue: 3
  year: 2002
  end-page: 234
  ident: 30
  article-title: In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome
– volume: 54
  start-page: 253
  issue: 3
  year: 1989
  end-page: 260
  ident: 17
  article-title: Continuous measurement of shear-induced platelet aggregation
– volume: 110
  start-page: 364
  issue: 4
  year: 2004
  end-page: 367
  ident: 6
  article-title: Association of atrial fibrillation and obstructive sleep apnea
– volume: 25
  start-page: 1547
  issue: 8
  year: 1994
  end-page: 1551
  ident: 18
  article-title: Shear-induced platelet aggregation in cerebral ischemia
– volume: 23
  start-page: 65
  issue: 1
  year: 2005
  end-page: 71
  ident: 10
  article-title: Hematologic ramifications of patent foramen ovale—role of hypercoagulable state
– volume: 18
  start-page: 551
  issue: 8
  year: 1991
  end-page: 555
  ident: 26
  article-title: Urinary excretion of prostanoids during sleep in obstructive sleep apnoea patients
– volume: 353
  start-page: 2034
  issue: 19
  year: 2005
  end-page: 2041
  ident: 3
  article-title: Obstructive sleep apnea as a risk factor for stroke and death
– volume: 32
  start-page: 448
  issue: 2
  year: 2001
  end-page: 453
  ident: 9
  article-title: Ear oximetry: a noninvasive method for detection of patent foramen ovale: a study comparing dye dilution method and oximetry with contrast transesophageal echocardiography
– volume: 37
  start-page: 127
  issue: 2
  year: 1998
  end-page: 133
  ident: 27
  article-title: Compensatory excretion of prostacyclin and thromboxane metabolites in obstructive sleep apnea syndrome
– volume: 7
  start-page: 35
  issue: 1
  year: 2003
  end-page: 51
  ident: 36
  article-title: Obstructive sleep apnoea syndrome—an oxidative stress disorder
– volume: 35
  start-page: 594
  issue: 6
  year: 2000
  end-page: 600
  ident: 19
  article-title: Effects of alcohol and the evening meal on shear-induced platelet aggregation and urinary excretion of prostanoids
– volume: 3
  start-page: 1879
  issue: 8
  year: 2005
  end-page: 1883
  ident: 22
  article-title: PAI-1 and atherothrombosis
– volume: 76
  start-page: 277
  year: 2000
  end-page: 278
  ident: 23
  article-title: Plasminogen activator inhibitor-1 in patients with ischemic stroke.
– volume: 3
  start-page: 35
  issue: 1
  year: 2005
  end-page: 45
  ident: 13
  article-title: Pleiotropic functions of plasminogen activator inhibitor-1
– volume: 104
  start-page: 3943
  issue: 13
  year: 2004
  end-page: 3948
  ident: 12
  article-title: Platelets synthesize large amounts of active plasminogen activator inhibitor 1
– volume: 10
  start-page: 139
  issue: 3
  year: 2006
  end-page: 146
  ident: 21
  article-title: Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure
– volume: 108
  start-page: 625
  issue: 3
  year: 1995
  end-page: 630
  ident: 28
  article-title: Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation
– volume: 25
  start-page: 856
  issue: 8
  year: 2002
  end-page: 862
  ident: 34
  article-title: Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovale
– ident: 12
  doi: 10.1182/blood-2004-04-1439
– volume: 142
  start-page: 187
  issue: 3
  year: 2005
  ident: 1
  publication-title: Annals of Internal Medicine
  doi: 10.7326/0003-4819-142-3-200502010-00010
– volume: 108
  start-page: 625
  issue: 3
  year: 1995
  ident: 30
  publication-title: Chest
  doi: 10.1378/chest.108.3.625
– ident: 2
  doi: 10.1016/S1474-4422(04)00766-5
– ident: 34
  doi: 10.1034/j.1399-3003.2000.16d14.x
– ident: 35
  doi: 10.1111/j.1365-2869.2005.00469.x
– ident: 7
  doi: 10.1378/chest.124.5.1956
– ident: 13
  doi: 10.1111/j.1538-7836.2004.00827.x
– volume: 51
  start-page: 188
  issue: 1
  year: 1998
  ident: 31
  publication-title: Neurology
  doi: 10.1212/WNL.51.1.188
– volume: 32
  start-page: 1271
  issue: 6
  year: 2001
  ident: 4
  publication-title: Stroke
  doi: 10.1161/01.STR.32.6.1271
– volume: 98
  start-page: 2241
  issue: 21
  year: 1998
  ident: 27
  publication-title: Circulation
  doi: 10.1161/01.CIR.98.21.2241
– volume: 25
  start-page: 1547
  issue: 8
  year: 1994
  ident: 19
  publication-title: Stroke
  doi: 10.1161/01.STR.25.8.1547
– volume: 20
  start-page: 1155
  issue: 4
  year: 2000
  ident: 14
  publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology
  doi: 10.1161/01.ATV.20.4.1155
– ident: 24
  doi: 10.1111/j.1538-7836.2005.01420.x
– ident: 6
  doi: 10.1161/01.CIR.0000136587.68725.8E
– volume: 32
  start-page: 448
  issue: 2
  year: 2001
  ident: 9
  publication-title: Stroke
  doi: 10.1161/01.STR.32.2.448
– volume: 35
  start-page: 594
  issue: 6
  year: 2000
  ident: 20
  publication-title: Alcohol and Alcoholism
  doi: 10.1093/alcalc/35.6.594
– volume: 25
  start-page: 856
  issue: 8
  year: 2002
  ident: 36
  publication-title: Sleep
– volume: 18
  start-page: 188
  issue: 3
  year: 1995
  ident: 21
  publication-title: Sleep
  doi: 10.1093/sleep/18.3.188
– volume: 162
  start-page: 2039
  issue: 6
  year: 2000
  ident: 26
  publication-title: American Journal of Respiratory and Critical Care Medicine
  doi: 10.1164/ajrccm.162.6.2001048
– ident: 15
  doi: 10.1182/blood-2006-04-011551
– ident: 5
  doi: 10.1161/01.CIR.0000072346.56728.E4
– volume: 54
  start-page: 253
  issue: 3
  year: 1989
  ident: 18
  publication-title: Thrombosis Research
  doi: 10.1016/0049-3848(89)90233-8
– ident: 16
  doi: 10.1097/00004872-200311000-00002
– volume: 76
  start-page: 277
  year: 2000
  ident: 25
  publication-title: Acta Neurochirurgica
– volume: 37
  start-page: 127
  issue: 2
  year: 1998
  ident: 29
  publication-title: Internal Medicine
  doi: 10.2169/internalmedicine.37.127
– ident: 10
  doi: 10.1016/j.ccl.2004.10.002
– volume: 113
  start-page: 91
  issue: 1
  year: 1998
  ident: 37
  publication-title: Chest
  doi: 10.1378/chest.113.1.91
– volume: 31
  start-page: 398
  issue: 2
  year: 2000
  ident: 11
  publication-title: Stroke
  doi: 10.1161/01.STR.31.2.398
– ident: 38
  doi: 10.1053/smrv.2002.0261
– ident: 22
  doi: 10.1007/s11325-006-0060-3
– volume: 18
  start-page: 551
  issue: 8
  year: 1991
  ident: 28
  publication-title: Clinical and Experimental Pharmacology and Physiology
  doi: 10.1111/j.1440-1681.1991.tb01490.x
– ident: 3
  doi: 10.1056/NEJMoa043104
– volume: 8
  start-page: 375
  year: 2012
  ident: 39
  publication-title: Journal of Clinical Sleep Medicine
  doi: 10.5664/jcsm.2026
– ident: 8
  doi: 10.4065/81.5.602
– ident: 32
  doi: 10.1159/000063625
– ident: 33
  doi: 10.1378/chest.125.5.1768
– reference: 8042205 - Stroke. 1994 Aug;25(8):1547-51
– reference: 14605073 - Chest. 2003 Nov;124(5):1956-67
– reference: 9826309 - Circulation. 1998 Nov 24;98(21):2241-7
– reference: 9550591 - Intern Med. 1998 Feb;37(2):127-33
– reference: 10764687 - Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1155-61
– reference: 2501904 - Thromb Res. 1989 May 1;54(3):253-60
– reference: 7610315 - Sleep. 1995 Apr;18(3):188-94
– reference: 11387486 - Stroke. 2001 Jun;32(6):1271-8
– reference: 15676269 - Cardiol Clin. 2005 Feb;23(1):65-71
– reference: 15634264 - J Thromb Haemost. 2005 Jan;3(1):35-45
– reference: 15136389 - Chest. 2004 May;125(5):1768-75
– reference: 11093967 - Alcohol Alcohol. 2000 Nov-Dec;35(6):594-600
– reference: 22893767 - J Clin Sleep Med. 2012;8(4):375-80
– reference: 11450024 - Acta Neurochir Suppl. 2000;76:277-8
– reference: 12097766 - Respiration. 2002;69(3):229-34
– reference: 7656607 - Chest. 1995 Sep;108(3):625-30
– reference: 16120109 - J Sleep Res. 2005 Sep;14(3):325-7
– reference: 11157181 - Stroke. 2001 Feb;32(2):448-53
– reference: 12586529 - Sleep Med Rev. 2003 Feb;7(1):35-51
– reference: 15249509 - Circulation. 2004 Jul 27;110(4):364-7
– reference: 16102055 - J Thromb Haemost. 2005 Aug;3(8):1879-83
– reference: 15684207 - Ann Intern Med. 2005 Feb 1;142(3):187-97
– reference: 12489891 - Sleep. 2002 Dec15;25(8):856-62
– reference: 1914253 - Clin Exp Pharmacol Physiol. 1991 Aug;18(8):551-5
– reference: 10657412 - Stroke. 2000 Feb;31(2):398-403
– reference: 11106207 - Eur Respir J. 2000 Oct;16(4):648-52
– reference: 12847053 - Circulation. 2003 Jul 8;108(1):9-12
– reference: 14597836 - J Hypertens. 2003 Nov;21(11):1983-92
– reference: 11112110 - Am J Respir Crit Care Med. 2000 Dec;162(6):2039-42
– reference: 9674801 - Neurology. 1998 Jul;51(1):188-95
– reference: 16282178 - N Engl J Med. 2005 Nov 10;353(19):2034-41
– reference: 15157848 - Lancet Neurol. 2004 Jun;3(6):333-42
– reference: 15315974 - Blood. 2004 Dec 15;104(13):3943-8
– reference: 16565866 - Sleep Breath. 2006 Sep;10(3):139-46
– reference: 9440574 - Chest. 1998 Jan;113(1):91-6
– reference: 16706256 - Mayo Clin Proc. 2006 May;81(5):602-8
– reference: 16772609 - Blood. 2006 Sep 15;108(6):1903-10
SSID ssj0000329304
Score 1.8772808
Snippet Obstructive sleep apnoea (OSA) carries an increased risk of ischaemic stroke, but the underlying mechanism is not clear. As right-to-left shunting can occur...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
hindawi
emarefa
airiti
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 584
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELbQJBAviF-DMEBG7AkpWhLHScMLKmjVQBqtNCbtzbLTi1ZRnGrtQPxH_Jl856RViyZ44aly_UNx7ovvzmd_J8Rh5gZ1XtZ13Li0jvOy0bGrlItdUeYclymyii84n34uTs7zTxf6YivVF58J6-iBuxd3RM2gAsoAO2gTvieUFGQHhSNrm1KpKa--SZVsOVNhDVZQYyF3IFfGA1gR_eU86E84_Gl2VHGEkBk07Yzpg3b0UqDvD3d0LcrQWbcv2UP-MbvJDv3zOOWWfhrdF_d6w1IOuwk9ELfIPxR3TvvQ-SPxa8SH-307_4kGclh3WSOk9VM5mcPghPzkCEqOBSVnXmJF4S2apeSdWjl2PdHsd5Jnc6KFHC58Szb0t3KCATz6t3zUy8sx4Etv5celBAqvCI3kOCxNEiayXLNGodg2aMTn9r_hmc5WV-1XevdYnI-Ov3w4ifs0DbHVpVrB-UxVaSHlFK9KcZi2UVRbSKygQQrlR6gtCihBGH_FVJGD9Oomd1XutEOXfbHnW09PhYSzQ1MI3CaU5KR0NYX91RRVZi01OrGROO6kZfovbWkmGe_ZlBynSA0LNs34pwxM94nWuwWI3OgqicSbtbBN3XOhc0qOuQk-UdcrMx1EInG4abzoKEBubvaeUbNpwrzd4Q-g2fRoNv9CcyT2e8xtxgmUhyoSr3sI_v0ZXq3habBMcOzHemqvlyZlGiPOJpBF4kkH181AMKp1BcsvEuUOkHemslvjZ5eBilxpztRVPvsfcz8Qd3kq3f7Wc7EHWNMLWHwr9zJ83L8BEvJKHg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbGEIgXxG0QbjJiT0iBJI6dBglNBa0aSKWVRqW9RU7isIrilLZc9o_4mXzHcSs6VYinys1x5Ph8Phcf-xzGDpOyV6VZVYVNGVdhmjUyLHNRhqXKUorLqCSnC87Dj-pkkn44k2d7bF2M00_gcqdrR_WkJovZy1_fLo6w4N-4BS8l_Pc4eZVTwC-_wq5CJSnywobeznciWUCruVKCSURXp2FU-Lt6l_pDD-kpZRPaUlMum7-7sqvRhgq7dk4O88_pLrP08unKv9TV4Ba76e1M3u-AcZvtGXuHXR_6SPpd9ntAZ_1tO7sAAe9XXREJrm3NxzPYn2AnH0DnEd_41HIIGNqxWXLauOWj0ued_WH46cyYOe_PbWu066_5GC-w6N_SyS_LR0Czec3fLzlAuTAg4iMnqTgsZr5OIoVm24CIjvF_xZhOV4v2izm6xyaD40_vTkJftSHUMhMr-KKxyDSYHmOqBEVtG2EqDbmhTC-GLjR4qhR0IhilamFKBRw1aZmnpSzR5YDt29aaB4zD9zF108t1ZKLUCJnXMMcalSdam0ZGOmDHHbeKNW6KcUJbOBmFLeKCGBsn9JO5xPeRlNsNsLyQeRSwF2tmF5VPjU4VOmaFc5G6XknRQSRghxvieZcRZDfZW0LNhoTSeLs_2sXnwkuFwuDjIEIxNzCV6BJcpIzuYT60bjIh6oAdeMxt3uMyIIqAPfcQ_PcYnq3hWUBqUChIW9N-XxYxZTWi4gJJwO53cN28CDa2zGEIBizbAvLWp2w_sdNzl5lcSCrclT38r9E9Yjeo1e1nPWb7wK15AgtvVT51q_cPCO9FJQ
  priority: 102
  providerName: Scholars Portal
Title Fibrinolytic Activity and Platelet Function in Subjects with Obstructive Sleep Apnoea and a Patent Foramen Ovale: Is There an Option for Prevention of Ischaemic Stroke?
URI https://www.airitilibrary.com/Article/Detail/P20150731001-201212-201706150055-201706150055-584-590
https://search.emarefa.net/detail/BIM-510323
https://dx.doi.org/10.1155/2012/945849
https://www.ncbi.nlm.nih.gov/pubmed/23259151
https://www.proquest.com/docview/1273447942
https://pubmed.ncbi.nlm.nih.gov/PMC3510867
https://doaj.org/article/ef89048225024146806ea86beaaf733d
Volume 2012
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJBAviK-x8DEZsSekiCSOnYQXVNCqgVRaMSb1LbJTR6soTrUWEP8Rfya_c9yKjgnx0srJ2XJ8P_vOd_YdY8eZKZu8aJq4NWkT50UrY1MJExtV5OSXUVlFF5xHH9Xpef5hKqfhgOzqbxc-pB2252n2qiJ_XrXH9kpF2P10Ot1aUhIBkeXzBGYJ3YuGxhAu4l2pDSGj5xQqaEcG-VD9_j6uRhny6eYF7YZ_zK_TOa8enfxDFg3vsjtBieSDnuv32A3r7rNbo-Amf8B-Dekgv-sWP0HAB02fIYJrN-OTBZRL8IoPIdCIKXzuOFYPMsesOFll-diEoLLfLT9bWLvkg6XrrPb1NZ-gAYf6HR3rcnwMqNrX_P2KA3GXFkR87JchDnWYbyJEodi1IKIz-l_Rp7P1ZffFvnnIzocnn9-dxiElQ6xlIdbYaKai0OBoiqES5JJthW00FgVlyxSCzuKtUhB4UPTUTFijAJI2N1VupEGVA7bvOmcPGcfGxs7astKJTXIrZDWDrtWqKtPatjLRETvpuVWHWbWqJxnZZwrySaQ1MTbN6K_wUe0TKXcLYHktqyRiLzfMrpsQ95zSbyxqv__pa2V1D5GIHW-Jl324j-vJ3hJqtiQUo9s_AG7rMOVri4_D-oixgR5EN9wSZXWJ8dC6LYSYRewgYG7bjg9vKCL2IkDw3314voFnjSWB_Dza2e7bqk4pZBFlDsgi9qiH67YhKNCygpYXsWIHyDufsvvGzS982HEhKStX8fi_eveE3aZSb6x6yvaBW_sM6tvaHHmzB35HeXnkZ_JvFz45gQ
linkProvider Hindawi Publishing
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fibrinolytic+Activity+and+Platelet+Function+in+Subjects+with+Obstructive+Sleep+Apnoea+and+a+Patent+Foramen+Ovale%3A+Is+There+an+Option+for+Prevention+of+Ischaemic+Stroke%3F&rft.jtitle=Stroke+research+and+treatment&rft.au=Reggiani%2C+Monica&rft.au=Karttunen%2C+Vesa&rft.au=Wartiovaara-Kautto%2C+Ulla&rft.au=Riutta%2C+Asko&rft.date=2012-01-01&rft.pub=Hindawi+Publishing+Corporation&rft.issn=2090-8105&rft.eissn=2042-0056&rft.volume=2012&rft_id=info:doi/10.1155%2F2012%2F945849&rft.externalDocID=10_1155_2012_945849
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fwww.airitilibrary.com%2Fjnltitledo%2FP20150731001-c.jpg